Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1065-2019

Drug recall · March 27, 2019

Etomidate Injection recall

Why: Subpotent Drug.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Etomidate Injection, USP 20 mg/10mL (2mg/mL) 10 mL Single-Dose Vial, Rx only, Manufactured for: Heritage Pharmaceuticals Inc. Made in India, NDC 23155-160-31

Lots / codes

Lot #: AMA701, Exp. March 2019; AMA702, AMA703, Exp August 2019.

Quantity
11888 units
Company
Heritage Pharmaceuticals, Inc., East Brunswick, NJ
Distribution
Nationwide within the United States
Initiated
February 15, 2019 · Voluntary: Firm initiated
Classified
March 27, 2019
Reported
March 27, 2019
Ended
March 4, 2021
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Etomidate

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.